Year-end Sale % OFF 
Abstract
Several anti-HIV microbicide trials have been conducted in recent years, but none have yielded positive results . . . until now. At this year’s Retrovirus Conference, Salim Abdool Karim presented the much-awaited results of HPTN 035, a phase II/IIb trial designed to assess the safety and efficacy of two microbicides for the prevention of HIV infection in …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
